explore -WSS

explore

author：entertainment 2025-09-27 23:02:03 - browse：4

The 7 a.m. Acela out of South Station in Boston trembled along the rails toward Manhattan. David Sabatini sat alone on the left side of the train. He had brought along a science paper to work on, but had a lot on his mind. He kept his Wordle streak alive on his phone, and stared out at the picturesque Connecticut coastline. His clothing hung loose from recent weight loss, presumably from stress.

It was Jan. 4, 2022, a brisk sunny day. The tall, gangling scientist with a long mess of black hair had once generated Nobel Prize buzz for his discoveries in biology. But at that moment, he was unemployed in his 50s, his reputation ruined, spending many nights in his brother’s guest room or on his ex-wife’s sofa, so emotionally distraught that his family was afraid to leave him alone.

Sabatini was journeying to New York in search of a new beginning, an against-all-odds comeback.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Health tech investors get more selective as pandemic boom fades

WSS

Roivant's CEO is a star, but biotech's black hole persists

How a symptom of dementia informs our understanding of creativity

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Results on Novartis prostate cancer therapy could expand its use

NYU Langone launches private ChatGPT for its health care data

How to make AI work for medicine

hotspot

explore

focus

Duchenne breakthrough therapy leaves behind pioneering families

2024 GOP presidential candidates spar over abortion in debate

DIEP, the 'gold standard' of breast reconstruction, is under threat

The problems with dementia villages

Heart attack and stroke risk calculators need revising

STAT Readout Newsletter: Biotech news today

Activists slam private health insurers over coverage restrictions

How to make Best Hospitals ratings actually useful for patients

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Roche acquires Telavant from Roivant, adding experimental IBD treatment

hotspot

Roche drug slashes death risk in early

Study on Amgen’s bispecific immunotherapy produces positive data

Radiation, mainstay of cancer treatment, begins a fade

STAT Summit: Meghan O’Rourke on making chronic illness visible

Feds fine Medicare Advantage plans for overcharging members

How to make AI work for medicine

knowledge

focus

knowledge

focus